Creek Drive Management Group LLC
Position in RNA — Atrium Therapeutics, Inc.
CIK 2111824
SAN FRANCISCO, CA
Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,604,400
New position
Shares Held
120,000
first reported quarter
Ownership
0.702%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Creek Drive Management Group LLC holds $33,530,780 across 8 Biotechnology names. RNA ranks #4 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
155,000 | $17,259,250 | |
| 2 | NKTR |
Nektar Therapeutics
|
126,400 | $9,094,480 | |
| 3 | QURE |
uniQure N.V.
|
150,000 | $2,452,500 | |
| 4 | RNA |
Atrium Therapeutics, Inc.
This page
|
120,000 | $1,604,400 | |
| 5 | PALI |
Palisade Bio, Inc.
|
540,000 | $945,000 | |
| 6 | PEPG |
PepGen Inc.
|
450,000 | $796,500 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
45,000 | $719,550 | |
| 8 | CYTK |
Cytokinetics Inc
|
10,000 | $659,100 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,604,400 | 120,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||